[ad_1]
The authors of the study, developed by experts from the ECDC and the AMR task force, and published in The Lancet Infectious Diseases, report that the estimated burden of antibiotic-resistant bacteria EU / EEA is important compared to other countries. infectious diseases, and has increased since 2007. They state, "Strategies for prevention and control of antibiotic-resistant bacteria require coordination at the European / EEE and global level.However, our study has shown that the contribution of various bacteria antibiotics resistant to the overall burden varies considerably from one country to another, thus highlighting the need for prevention and control strategies adapted to the needs of each EU / EEA country ".
The study estimates that about 33,000 people die each year from direct consequences of an infection with an antibiotic-resistant bacterium and that the burden of these infections is comparable to that of influenza, tuberculosis and HIV / AIDS combined. This also explains that 75% of the disease burden is due to healthcare-associated infections and that reducing it through appropriate infection prevention and control measures, as well as antibiotic management, could be a feasible goal. in health care facilities.
Finally, the study shows that 39% of the load is caused by infections with bacteria resistant to the last-line antibiotics, such as carbapenems and colistin. This is an increase from 2007 and is of concern as these antibiotics are the last available treatment options. When these are no longer effective, it is extremely difficult, if not impossible, to treat infections.
Source: ECDC
Source link
